Glaucoma Trial, Recruiting NCT05885022 Sponsor: Myra Vision Inc. Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT05885022
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with open angle glaucoma, pseudoexfoliative glaucoma, or pigmentary glaucoma
  • Your eye pressure (measured before the procedure) is between 18 and 45 mmHg
  • Your vision test shows a certain level of sight loss, specifically a visual field mean deviation score of -3dB or worse (confirm with trial site)
  • There is a healthy, clear, and movable area of the thin tissue covering the white of your eye (called the conjunctiva) in the area where the procedure would take place
  • The drainage angle in your eye meets a specific measurement requirement called a Shaffer grade of 3 or higher (confirm with trial site)

Who may not be able to join:

  • You have angle closure glaucoma (a different type of glaucoma where the drainage angle is blocked)
  • You have glaucoma caused by other conditions, such as abnormal blood vessel growth or a condition present from birth
  • You have had previous eye surgery, unless it was a laser treatment for glaucoma or a straightforward cataract removal that took place more than 3 months before your pre-surgery visit
  • You have had a glaucoma drainage device or valve placed in the same area of the eye being studied
  • You have had a significant eye infection or inflammation in the eye being studied within the last 30 days
  • You have a history of corneal surgery, scarring, or disease affecting the clear front surface of your eye
  • You currently have active diabetic retinopathy (eye damage caused by diabetes)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Keith Barton, MD, Moorfields Eye Hospital NHS Foundation Trust

Phone: 14085602500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Myra Vision Inc.
Registry
ClinicalTrials.gov
Start date
31 May 2023
Est. completion
1 December 2027

Where this trial is recruiting

🇮🇳 India 🇲🇽 Mexico Panama

Primary endpoints

Intraocular Pressure; Adverse Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov